Hydrogenology
Hydrogenology editorial study record

Effect of molecular hydrogen on uterine inflammation during preterm labour

Nakano T, Kotani T, Imai K, Iitani Y, Ushida T, Tsuda H, Li H, Iwase A, Toyokuni S, Kikkawa F. · Biomedical Reports. 2018;8(5):454-460.

PreclinicalH₂-rich waterPublished 2018
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Randomized controlled pregnant-mouse prevention experiment

Research topic

Women’s health

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Thirty-eight pregnant ICR mice in an acute lipopolysaccharide model of inflammation-associated preterm labour.

Sample

For uterine/serum outcomes, control, LPS and H₂-water plus LPS groups had n=6 each. For delivery timing, separate LPS and H₂-water plus LPS groups had n=10 each; no delivery-timing control group was used.

Duration

Pretreatment began 24 hours before LPS; uterine/serum outcomes were collected six hours after LPS, and delivery was monitored hourly.

Intervention

H₂-rich drinking water began 24 hours before LPS administration on embryonic day 15.5 and continued until sacrifice or delivery assessment; mice drank approximately 200 mL/kg/day.

Hydrogen form

H₂ dissolved in drinking water — H₂ only, not Brown's gas.

H₂ specification

Donated water was stored above 0.4 mM and delivered through degassing-resistant glass bottles; drinking-water H₂ was maintained above 0.2 mM and replaced every 24 hours.

H₂ flow

Not applicable — drinking water, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

LPS-exposed mice receiving ordinary water and, for molecular outcomes, a PBS-injected control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Time to delivery, preterm-birth proportion, progesterone, uterine inflammatory cytokine transcripts, contractile-associated proteins, Mmp3, Et1 and Cox2 protein.

Reported result

H₂ water delayed mean delivery after LPS and changed several inflammatory/contractile markers. It did not significantly reduce preterm birth within 24 hours (90% vs 60%, p=0.303), Il8 was unchanged versus LPS, and the Mmp3 reduction was not significant (p=0.055). The authors concluded that prevention of acute-inflammation preterm birth was weak/ineffective despite molecular effects.

Results-extraction completeness

The complete free PMC article was checked for both cohorts, randomization, H₂ source/concentration/intake, timing, positive and null outcomes, stated limitations, donation, funding and conflict declaration.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Small mouse cohorts, preventive treatment before acute LPS exposure, no delivery-timing control arm, no neonatal clinical outcomes and many molecular comparisons. Blue Mercury donated the H₂ water; Japanese public grants funded the study, and authors declared no competing interests.

Applies directly to

Acute LPS-associated preterm labour in mice; it does not establish prevention or treatment of human preterm birth.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 29732148 · DOI: 10.3892/br.2018.1082

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Record revision

2026-08-10